20 May 2003 : Original article
Albumin dialysis (MARS)as a new supportive treatment in patients with hepatic encephalopathy
J. Rubik, S. Prokurat, J. Pawłowska, R. Grenda, P. Kaliciński, M. Migdał, A. KamińskiMed Sci Monit 2003; 9(2): 77-81 :: ID: 15327
Abstract
Hepatic encephalopathy (HE)may occur in patients with acute and decompensated chronic liver failure.One of the pathogenetic mechanisms is accumulation of ‘liver ’toxins such as ammonia in astrocytes causing brain oedema.In cases of acute liver failure deterioration of patient ’s condition to coma may be rapid and outcome poor.Multiple attempts have been made to reduce mortality of patients with HE.Urgent liver transplantation is considered as treatment of choice in most patients.Many therapies have been used to remove ‘liver ’toxins from circulation:dialysis, hemoperfusion, plasmapheresis, extracorporeal liver perfusion and others.None of them remained in routine clinical practice.Recently a new cell-free method designed for the selective removal of albumin-bound substances normally cleared by the liver (MARS –Molecular Adsorbent Recirculating System) is available. We have been using this method in Children ’s Memorial Health Institute since July 2001 to support vital functions in some patients listed for liver transplantation.Till now we have performed 11 sessions in 7 patients with acute liver failure and hepatic encephalopathy.Four patients survived (one recovered without liver transplantation and three were transplanted) and three patients died (two before organ for transplantation was available and one during surgical procedure).We have obtained decrease of serum toxins concentration (ammonia, bilirubine, creatinine and others) and clinical improvement. In our opinion albumin dialysis MARS is promising new method of detoxification in critically ill patients with liver dysfunction.
Keywords: hepatic encephalopathy, albumin dialysis, Mars
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
08 Mar 2024 : Animal Research
Modification of Experimental Model of Necrotizing Enterocolitis (NEC) in Rat Pups by Single Exposure to Hyp...Med Sci Monit In Press; DOI: 10.12659/MSM.943443
18 Apr 2024 : Clinical Research
Comparative Analysis of Open and Closed Sphincterotomy for the Treatment of Chronic Anal Fissure: Safety an...Med Sci Monit In Press; DOI: 10.12659/MSM.944127
08 Mar 2024 : Laboratory Research
Evaluation of Retentive Strength of 50 Endodontically-Treated Single-Rooted Mandibular Second Premolars Res...Med Sci Monit In Press; DOI: 10.12659/MSM.944110
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952